GlobeNewswire Inc.··NaMangoceuticals Files Global Patent for MGX-0024 Avian Antiviral as H5N1 Protection Expands
Mangoceuticals files PCT patent application for MGX-0024 antiviral additive, following clinical trials showing zero mortality in 29,000 birds against H5N1 avian influenza.
MGRXintellectual propertyglobal expansion